Caleres Inc. (NYSE:CAL) stock rose Wednesday after the footwear company reported second-quarter earnings that beat Wall Street expectations and raised its full-year adjusted earnings outlook.Caleres reported adjusted earnings of 47 cents per share, beating the consensus estimate of 37 cents.Sales…
The 10-year Treasury yield climbed six basis points to 4.85% Wednesday, its highest since October 2023, as Brent crude above $100 revived inflation fears ahead of next week’s Fed meeting. The move held even after the Treasury Department tripled Thursday’s…
Compass Pathways plc (NASDAQ:CMPS) on Wednesday shared topline 52-week Part C results from its Phase 3 COMP005 study evaluating COMP360, a proprietary synthetic formulation of psilocybin, for treatment-resistant depression. Following the announcement, the stock jumped over 11%. The updated data…
The bond selloff is creating an unusual split among ETF investors. Money is pouring into both ultra-short Treasuries and long-duration government debt, suggesting investors are positioning for very different outcomes as inflation, oil prices, and fiscal concerns reshape the interest-rate…
Artificial intelligence infrastructure companies have spent the past two years raising prices as demand for high-end GPUs outpaced supply. Nebius Group N.V. (NASDAQ:NBIS) just revealed that even repeated price hikes weren’t enough. Instead, the company turned to auctions—and customers voluntarily…
U.S. equities slid across the board at midday Wednesday as Brent crude pushed above $100 a barrel for the first time since July and the 10-year Treasury yield climbed to a three-year high, reviving the inflation-and-rate-hike trade that has dogged…
ODDITY Tech Ltd. (NASDAQ:ODD) stock surged Wednesday after the beauty and wellness company reported better-than-expected second-quarter results and issued third-quarter and full-year sales guidance above Wall Street estimates.The rally was likely magnified by elevated short interest, with 32% of the…
A public feud over tokenized stocks spilled from social media onto television Wednesday, with Robinhood Markets, Inc. (NASDAQ:HOOD) CEO Vlad Tenev pushing back on claims that his company oversteps its bounds. Once a company goes public, he argued, that company…
Tyra Biosciences Inc. (NASDAQ:TYRA) stock is trading lower on Wednesday after the company shared initial results from its Phase 2 SURF302 trial evaluating oral dabogratinib, delivering clinical proof of concept and identifying a 60 mg once-daily dose to support planned…
Shares of Braze Inc (NASDAQ:BRZE) tanked on Wednesday, despite the company reporting upbeat fiscal second-quarter results. Here are some key analyst takeaways: Stephens analyst Brett Huff maintained an Overweight rating, while raising the price target from $31 to $34. Citizens…